1104280--12/3/2010--SANGUI_BIOTECH_INTERNATIONAL

related topics

{product, liability, claim}

{product, candidate, development}

{operation, international, foreign}

{interest, director, officer}

{control, financial, internal}

{cost, regulation, environmental}

{stock, price, share}

{property, intellectual, protect}

{acquisition, growth, future}

Risk that SGBI's Common Stock may be deemed a Penny Stock Conflicts of Interest; Related Party Transactions Limited Operating History of the Company; Losses Are Expected To Continue Substantial Doubt that the Company Can Continue as a Going Concern Future Capital Needs and Uncertainty of Additional Funding Early Stage of Product Development; Lack of Commercial Products; No Assurance of Successful Product Development Government Regulation; No Assurance of Product Approval Uncertainties Associated With Patents and Proprietary Rights Risk of Product Liability; Potential Unavailability of Insurance Uncertainties Relating to Pricing and Third-Party Reimbursement Risk of Product Recall; Product Returns Risks of International Sales and Operations Lack of Commercial Manufacturing and Marketing Experience Hazardous Materials And Environmental Matters Fluctuations in Foreign Currency Exchange Rates could have an Adverse Impact.

Full 10-K form ▸

1104280--12/3/2010--SANGUI_BIOTECH_INTERNATIONAL_INC